Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic

Karin Yaacoby-Bianu; Galit Livnat; James D. Chalmers; Michal Shteinberg

doi:10.1183/23120541.00114-2022

Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic

Karin Yaacoby-Bianu
, Galit Livnat
, James D. Chalmers
, Michal Shteinberg

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

131 Downloads (Pure)

Abstract

Respiratory professionals support the continuing use of protective measures for respiratory patients following the #COVID19 pandemic. The optimal use of these measures should be considered in clinical guidelines and public health recommendations.

Original language	English
Article number	00114-2022
Number of pages	4
Journal	ERJ Open Research
Volume	8
Issue number	4
DOIs	https://doi.org/10.1183/23120541.00114-2022
Publication status	Published - 4 Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/23120541.00114-2022Licence: CC BY-NC

Final published versionFinal published version, 326 KBLicence: CC BY-NC

Cite this

@article{7b6153dfc5104d7685d92ba195c9a938,

title = "Respiratory healthcare professionals{\textquoteright} views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic",

abstract = "Respiratory professionals support the continuing use of protective measures for respiratory patients following the \#COVID19 pandemic. The optimal use of these measures should be considered in clinical guidelines and public health recommendations.",

author = "Karin Yaacoby-Bianu and Galit Livnat and Chalmers, \{James D.\} and Michal Shteinberg",

note = "Funding Information: Conflict of interest: K. Yaacoby-Bianu reports grants from Vertex Pharmaceuticals and Gilead outside the submitted work. G. Livnat reports grants and nonfinancial support from Vertex Pharmaceuticals, and grants from Enanta Pharmaceuticals, MedImmune and DoseNTRX, outside the submitted work. J.D. Chalmers reports grants and personal fees from Astrazeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Insmed, personal fees from Chiesi, Zambon, Janssen and Grifols, and grants from Gilead Science, outside the submitted work; and is an associate editor of this journal. M. Shteinberg reports grants, personal fees and nonfinancial support from GSK, grants and personal fees from Novartis, personal fees from Boehringer Ingelheim, Zambon, AstraZeneca, Kamada, Vertex Pharmaceuticals, Teva and Bonus Therapeutics, and nonfinancial support from Actelion and Rafa, outside the submitted work.",

year = "2022",

month = oct,

day = "4",

doi = "10.1183/23120541.00114-2022",

language = "English",

volume = "8",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "4",

}

TY - JOUR

T1 - Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic

AU - Yaacoby-Bianu, Karin

AU - Livnat, Galit

AU - Chalmers, James D.

AU - Shteinberg, Michal

N1 - Funding Information: Conflict of interest: K. Yaacoby-Bianu reports grants from Vertex Pharmaceuticals and Gilead outside the submitted work. G. Livnat reports grants and nonfinancial support from Vertex Pharmaceuticals, and grants from Enanta Pharmaceuticals, MedImmune and DoseNTRX, outside the submitted work. J.D. Chalmers reports grants and personal fees from Astrazeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Insmed, personal fees from Chiesi, Zambon, Janssen and Grifols, and grants from Gilead Science, outside the submitted work; and is an associate editor of this journal. M. Shteinberg reports grants, personal fees and nonfinancial support from GSK, grants and personal fees from Novartis, personal fees from Boehringer Ingelheim, Zambon, AstraZeneca, Kamada, Vertex Pharmaceuticals, Teva and Bonus Therapeutics, and nonfinancial support from Actelion and Rafa, outside the submitted work.

PY - 2022/10/4

Y1 - 2022/10/4

N2 - Respiratory professionals support the continuing use of protective measures for respiratory patients following the #COVID19 pandemic. The optimal use of these measures should be considered in clinical guidelines and public health recommendations.

AB - Respiratory professionals support the continuing use of protective measures for respiratory patients following the #COVID19 pandemic. The optimal use of these measures should be considered in clinical guidelines and public health recommendations.

UR - https://www.scopus.com/pages/publications/85139383106

U2 - 10.1183/23120541.00114-2022

DO - 10.1183/23120541.00114-2022

M3 - Letter

C2 - 36199591

AN - SCOPUS:85139383106

SN - 2312-0541

VL - 8

JO - ERJ Open Research

JF - ERJ Open Research

IS - 4

M1 - 00114-2022

ER -

Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this